Azitra (AZTR) Assets Average (2023 - 2026)
Azitra (AZTR) reported Assets Average of $8.6 million for Q1 2026, up 29.29% on a YoY basis from $6.6 million in Q1 2025, and up 83.92% quarter-over-quarter from $4.7 million in Q4 2025.
Azitra (AZTR) Assets Average (2023 - 2026) Analysis & Trends
Azitra has reported Assets Average for 4 years, with the latest figure at $8.6 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 29.29% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 29.29% YoY), and the FY2025 full-year result was $6.2 million, down 0.72% from the prior year.
- Assets Average for Q1 2026 stood at $8.6 million, up from $4.7 million in the prior quarter.
- The five-year high for Assets Average was $8.7 million in Q3 2023, with the low at $4.1 million in Q3 2025.
- Historically, Assets Average has averaged $6.4 million across 4 years, with a median of $6.3 million in 2023.
- Annual changes were most pronounced in 2024 — Assets Average jumped 35.94% — and 2025, when it slumped 45.58%.
- Azitra's Assets Average stood at $6.3 million in 2023, then jumped by 35.94% to $8.6 million in 2024, then tumbled by 45.58% to $4.7 million in 2025, then jumped by 83.92% to $8.6 million in 2026.
- The last three Assets Average figures came in at $8.6 million (Q1 2026), $4.7 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 8.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.58 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | 4.13 Mn |
| Jun 30, 2025 | 4.93 Mn |
| Mar 31, 2025 | 6.63 Mn |
| Dec 31, 2024 | 8.57 Mn |
| Sep 30, 2024 | 6.83 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 5.59 Mn |
| Dec 31, 2023 | 6.30 Mn |
| Sep 30, 2023 | 8.66 Mn |